
SPRY
ARS Pharmaceuticals Inc
Biotechnology
ARS Pharmaceuticals Inc (SPRY) Stock News
The latest SPRY headlines and market coverage — 1 recent story, updated throughout the day.
- GlobeNewswire Inc.·
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY)
A securities class action lawsuit has been filed against ARS Pharmaceuticals Inc. for allegedly providing misleading statements about expanded insurance coverage for its epinephrine nasal spray product neffy through CVS Caremark. The company failed to disclose risks that the July 1, 2026 coverage deadline might not be met. When the truth emerged on June 24, 2026, ARS stock declined over 23.9% in a single day.